Lu, Y., Hong, B., Li, H., Zheng, Y., Zhang, M., Wang, S., . . . Yi, Q. (2014). Tumor-specific IL-9–producing CD8(+) Tc9 cells are superior effector than type-I cytotoxic Tc1 cells for adoptive immunotherapy of cancers. National Academy of Sciences.
Chicago Stili AlıntıLu, Yong, Bangxing Hong, Haiyan Li, Yuhuan Zheng, Mingjun Zhang, Siqing Wang, Jianfei Qian, ve Qing Yi. Tumor-specific IL-9–producing CD8(+) Tc9 Cells Are Superior Effector Than Type-I Cytotoxic Tc1 Cells for Adoptive Immunotherapy of Cancers. National Academy of Sciences, 2014.
MLA AlıntıLu, Yong, et al. Tumor-specific IL-9–producing CD8(+) Tc9 Cells Are Superior Effector Than Type-I Cytotoxic Tc1 Cells for Adoptive Immunotherapy of Cancers. National Academy of Sciences, 2014.